Clinical and molecular characterization of Wilson's disease in China: identification of 14 novel mutations
2011

Study of Wilson's Disease in China: New Mutations Identified

Sample size: 62 publication Evidence: moderate

Author Information

Author(s): Li Xin-Hua, Lu Yi, Ling Yun, Fu Qing-Chun, Xu Jie, Zang Guo-Qing, Zhou Feng, De-Min Yu, Han Yue, Zhang Dong-Hua, Gong Qi-Ming, Lu Zhi-Meng, Kong Xiao-Fei, Wang Jian-She, Zhang Xin-Xin

Primary Institution: Shanghai Jiaotong University School of Medicine

Hypothesis

The study aims to expand knowledge of ATP7B mutations and characterize Wilson's disease in the Chinese population.

Conclusion

The study identified 14 novel mutations in the ATP7B gene and highlighted the distinct mutation spectrum of Wilson's disease in China compared to Western countries.

Supporting Evidence

  • Neurologic symptoms were linked to older age at diagnosis and longer diagnostic delays.
  • 14 novel mutations were identified, expanding the known mutation spectrum.
  • Genetic testing is crucial for early diagnosis, especially in children under 8 years old.

Takeaway

Wilson's disease is a rare condition that affects how the body processes copper, and this study found new genetic mutations in Chinese patients that can help doctors diagnose it better.

Methodology

Direct sequencing of the ATP7B gene coding and promoter regions was performed on 62 patients with Wilson's disease.

Limitations

The study primarily focused on a specific population in China, which may limit the generalizability of the findings.

Participant Demographics

62 patients (58 probands) from the Chinese Han population, including 37 males and 25 females, aged 2 to 61 years.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2350-12-6

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication